Quinazolinones as inhibitors of human phosphatidylinositol...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S277000, C544S287000

Reexamination Certificate

active

07932260

ABSTRACT:
The invention provides a class of substituted quinazolinone compounds and methods of treating diseases mediated by PI3Kδ activity. The disclosed compounds are useful in treating diseases such as bone-resorption disorders; and cancer, especially hematopoietic cancers, lymphomas, multiple myelomas and leukemia. The compounds are also useful in disrupting or inhibiting cellular processes such as leukocyte function or accumulation, neutrophils function, lymphocyte proliferation, and endogenous immune responses.

REFERENCES:
patent: 3322756 (1967-05-01), Ruschig et al.
patent: 3691016 (1972-09-01), Patel
patent: 3897432 (1975-07-01), Shen et al.
patent: 3969287 (1976-07-01), Jaworek et al.
patent: 3984555 (1976-10-01), Amschler et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 4183931 (1980-01-01), Wolfe et al.
patent: 4195128 (1980-03-01), Hildebrand et al.
patent: 4225489 (1980-09-01), Rolf et al.
patent: 4229537 (1980-10-01), Hodgins et al.
patent: 4247642 (1981-01-01), Hirohara et al.
patent: 4289872 (1981-09-01), Denkewalter et al.
patent: 4301144 (1981-11-01), Iwashita et al.
patent: 4330440 (1982-05-01), Ayers et al.
patent: 4496689 (1985-01-01), Mitra
patent: 4640835 (1987-02-01), Shimizu et al.
patent: 4670417 (1987-06-01), Iwasaki et al.
patent: 4791192 (1988-12-01), Nakagawa et al.
patent: 4925673 (1990-05-01), Steiner et al.
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5225347 (1993-07-01), Goldberg et al.
patent: 5229490 (1993-07-01), Tam
patent: 5378725 (1995-01-01), Bonjouklian et al.
patent: 5480906 (1996-01-01), Creemer et al.
patent: RE35862 (1998-07-01), Steiner et al.
patent: 5858753 (1999-01-01), Chantry et al.
patent: 5882910 (1999-03-01), Chantry et al.
patent: 5948664 (1999-09-01), Williams et al.
patent: 5985589 (1999-11-01), Chantry et al.
patent: 6046049 (2000-04-01), Monia et al.
patent: 6048970 (2000-04-01), Lal et al.
patent: 6277981 (2001-08-01), Tu et al.
patent: 6291220 (2001-09-01), Williams et al.
patent: 6369038 (2002-04-01), Blumenfeld et al.
patent: 6410224 (2002-06-01), Stinchcomb et al.
patent: 6482623 (2002-11-01), Vanhaesebroeck et al.
patent: 6518277 (2003-02-01), Sadhu et al.
patent: 6667300 (2003-12-01), Sadhu et al.
patent: 6696250 (2004-02-01), Cech et al.
patent: 6800620 (2004-10-01), Sadhu et al.
patent: 6949535 (2005-09-01), Sadhu et al.
patent: 2002/0161014 (2002-10-01), Sadhu et al.
patent: 2003/0195211 (2003-10-01), Sadhu et al.
patent: 2004/0023390 (2004-02-01), Davidson et al.
patent: 2004/0092561 (2004-05-01), Ruckle et al.
patent: 2004/0121996 (2004-06-01), Barvian et al.
patent: 2004/0138199 (2004-07-01), Goglietti et al.
patent: 2004/0242631 (2004-12-01), Garlich et al.
patent: 2004/0248953 (2004-12-01), Gogliotti et al.
patent: 2004/0248954 (2004-12-01), Gogliotti et al.
patent: 2004/0259926 (2004-12-01), Bruendle et al.
patent: 2004/0266780 (2004-12-01), Sadhu et al.
patent: 2005/0004195 (2005-01-01), Para et al.
patent: 2005/0020630 (2005-01-01), Connolly et al.
patent: 2005/0020631 (2005-01-01), Gogliotti et al.
patent: 2005/0043239 (2005-02-01), Douangpanya et al.
patent: 2005/0054614 (2005-03-01), Diacovo et al.
patent: 2005/0239809 (2005-10-01), Watts et al.
patent: 2005/0261317 (2005-11-01), Sadhu et al.
patent: 2006/0079538 (2006-04-01), Hallahan et al.
patent: 2006/0106038 (2006-05-01), Bouscary et al.
patent: 2008/0275067 (2008-11-01), Fowler et al.
patent: 2008/0287469 (2008-11-01), Diacovo et al.
patent: 2010/0029693 (2010-02-01), Douangpanya et al.
patent: 2010/0152211 (2010-06-01), Sadhu et al.
patent: 2010/0168139 (2010-07-01), Sadhu et al.
patent: 2010/0202963 (2010-08-01), Gallatin et al.
patent: 2010/0249155 (2010-09-01), Evarts et al.
patent: 2010/0256167 (2010-10-01), Fowler et al.
patent: 2010/0256168 (2010-10-01), Fowler et al.
patent: 0 525 960 (1993-02-01), None
patent: 0 675 124 (1995-10-01), None
patent: 0 716 857 (1996-06-01), None
patent: 0 884 310 (1998-12-01), None
patent: 0 900 568 (1999-03-01), None
patent: 1356763 (1974-06-01), None
patent: 2017097 (1979-10-01), None
patent: 55-118917 (1980-09-01), None
patent: 55-118918 (1980-09-01), None
patent: 56-002322 (1981-01-01), None
patent: WO-93/21259 (1993-10-01), None
patent: WO-94/17090 (1994-08-01), None
patent: WO-95/24379 (1995-09-01), None
patent: WO-96/04923 (1996-02-01), None
patent: WO-96/25488 (1996-08-01), None
patent: WO-96/32478 (1996-10-01), None
patent: WO-97/34631 (1997-09-01), None
patent: WO-97/41097 (1997-11-01), None
patent: WO-97/43276 (1997-11-01), None
patent: WO-97/46688 (1997-12-01), None
patent: WO-98/33802 (1998-08-01), None
patent: WO-98/38173 (1998-09-01), None
patent: WO-99/08501 (1999-02-01), None
patent: WO-99/34804 (1999-07-01), None
patent: WO-01/00881 (2001-01-01), None
patent: WO-01/30768 (2001-05-01), None
patent: WO-01/53266 (2001-07-01), None
patent: WO-01/57034 (2001-08-01), None
patent: WO-01/81346 (2001-11-01), None
patent: WO-03/035075 (2003-05-01), None
patent: WO-03/106622 (2003-12-01), None
patent: WO-2004/007491 (2004-01-01), None
patent: WO-2004/012768 (2004-02-01), None
patent: WO-2004/026285 (2004-04-01), None
patent: WO-2004/029055 (2004-04-01), None
patent: WO-2004/052373 (2004-06-01), None
patent: WO-2004/056820 (2004-07-01), None
patent: WO-2004/089925 (2004-10-01), None
patent: WO-2004/108708 (2004-12-01), None
patent: WO-2004/108709 (2004-12-01), None
patent: WO-2004/108713 (2004-12-01), None
patent: WO-2004/108715 (2004-12-01), None
patent: WO-2005/016348 (2005-02-01), None
patent: WO-2005/016349 (2005-02-01), None
patent: WO-2005/067901 (2005-07-01), None
patent: WO-2005/120511 (2005-12-01), None
patent: WO-2009/058361 (2009-05-01), None
patent: WO-2010/065923 (2010-06-01), None
patent: WO-2010/123931 (2010-10-01), None
Jordan, V. C. Nature Reviews: Drug Discovery, 2, 2003, 205.
Vippagunta, et al. Advanced Drug Delivery Reviews, 48, 2001, 18.
Wolff, Manfred E., Ed. Burger's Medicinal Chemistry and Drug Discovery—Fifth Edition, New York: John Wiley & Sons, 1996, vol. 1, 975-976.
Burgering et al., Nature (1995) 376:599-602.
Chantry et al., J. Biol. Chem. (1997) 272:19236-19241.
Fraser et al., Science (1991) 251:313-316.
Fruman et al., Ann. Rev. Biochem. (1998) 67:481-507.
Hiles et al., Cell (1992) 70:419-429.
Hu et al., Mol. Cell. Biol. (1993) 13:7677-7688.
Hunter, Cell (1995) 83:1-4.
International Search Report for PCT/US2005/016778, mailed on Aug. 29, 2005, 4 pages.
Klippel et al., Mol. Cell. Biol. (1994) 14:2675-2685.
Krugmann et al., J. Biol. Chem. (1999) 274:17152-17158.
Lemmon et al., Trends Cell. Biol. (1997) 7:237-242.
Otsu et al., Cell (1991) 65:91-104.
Pages et al., Nature (1994) 369:327-329.
Panayotou et al., Trends Cell, Biol. (1992) 2:358-360.
Parker et al., Curr. Biol. (1995) 5:577-599.
Rameh et al., Cell (1995) 83:821-830.
Rameh et al., J. Biol. Chem. (1999) 274:8347-8350.
Rudd, Immunity (1996) 4:527-534.
Stenmark et al., J. Cell. Sci. (1999) 112:4175-4183.
Stoyanov et al., Science (1995) 269:690-693.
Thelen et al., PNAS USA (1994) 91:4960-4964.
Vanhaesebroeck et al., PNAS USA (1997) 94:4330-4335.
Volinia et al., Oncogene (1992) 7:789-793.
Yao et al., Science (1995) 267:2003-2005.
Chern et al., Chem. Pharm. Bull. (1998) 46(6):928-933.
El-Feky, Bollettino Chimico Farmaceutico (1998) 137:286-289.
El-Feky et al., Egypt. J. Pharm. Sci. (1983) 24(1-4):39-47.
Ismail and Sayed, Indian Journal of Chemistry (1982) 21B(5):461-462.
Parasharya and Parikh, J. Inst. Chemists (1992) 64(5):184-185.
Abu-Duhier et al., Br. J. Haematol. (2001) 113:983-988.
Adamkiewicz, “Tumor Angiogenesis: Mechanisms” IMT Marburg—Research Group, retrieved from the internet on Apr. 13, 2004, URL: http://www.imt.uni-marburg.de/—adamkiew/mechanism.html.
Ager et al., J. Med. Chem. (1977) 20:379-386.
Ali et al., Nature (2004) 431:1007-1011.
Alon et al., “The molecular basis of leukocyte adhesion to and migration through vascular endothelium,” Mirelman et al. (eds.), Life Sciences Open Day Book 2002, Weizmann Institute of Science, Life Sciences Department, Chapter 8, vol. 2:206-207 (2002), retrieved from the internet on Sep. 2, 2005, URL: http

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Quinazolinones as inhibitors of human phosphatidylinositol... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinazolinones as inhibitors of human phosphatidylinositol..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazolinones as inhibitors of human phosphatidylinositol... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2640325

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.